FELLVIEW HEALTHCARE
ST. BRIDGETS LANE, EGREMONT
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 41 | 45 | 91.1% | |
| HF 4 | 2011 | 42 | 55 | 76.4% | |
| HF 4 | 2012 | 85 | 106 | 80.2% | |
| HF 4 | 2013 | 79 | 101 | 78.2% | |
| HF004 | 2014 | 22 | 25 | 88.0% | |
| HF004 | 2015 | 21 | 23 | 91.3% | |
| HF004 | 2016 | 43 | 53 | 81.1% | |
| HF004 | 2017 | 69 | 69 | 100.0% | |
| HF004 | 2018 | 86 | 86 | 100.0% | |
| HF004 | 2019 | 102 | 130 | 78.5% | |
| HF004 | 2020 | 110 | 133 | 82.7% | |
| HF006 | 2021 | 127 | 157 | 80.9% | |
| HF006 | 2022 | 141 | 144 | 97.9% | |
| HF006 | 2023 | 133 | 148 | 89.9% |
